New crizotinib side-effect: Reduced measures of kidney function during treatment
Thursday, November 21, 2013 - 12:31
in Health & Medicine
A study shows that using crizotinib to treat ALK positive non-small cell lung cancer (NSCLC) appears to reduce kidney function when assessed by one of the most commonly used clinical methods.